A New Jersey pharmaceutical company has received a “conditional license” from the U.S. Department of Agriculture (USDA) for its bird flu vaccine for chickens.
Categories: Abril Elfianimal disease controlbiosecurity measuresbird flu vaccineCDC bird flu casesCentivaxcommercial poultry vaccinationeconomic impact on farmersH5N2 avian influenzahighly pathogenic avian influenza (HPAI)immune escape riskMahesh KumarOAN Newsroompandemic preventionpoultry healthTodays HeadlinesUSDA conditional licenseveterinary medicineZoetis